ALTRUA 2 (Model S722); ESSENTIO (Model L121); PROPONENT (Model L221); ACCOLADE (Model L321); ALTRUA 2 (Models S701,
Boston Scientific Corp · Decision date Oct 3, 2026
What did the FDA decide?
The FDA database entry for PMA number N970003, supplement S311, dated 2026-10-03, is a 30-Day Notice filed by Boston Scientific Corp under supplement reason 'Process Change - Manufacturer/Sterilizer/Packager/Supplier.' The listed device category is implantable pulse generator, pacemaker (non-CRT), specialty Cardiovascular, product code LWP. The source statement of purpose says the applicant intends 'to implement an additional acceptance activity for Accolade SL batteries and to change a specification for an existing Accolade EL battery specification.' The specific acceptance activity, the changed specification, and the technical reasoning are not stated in the supplied fields.
The S311 supplement attaches to the existing N970003 approval, not a new approval of a whole pacemaker system. The manufacturer also lists ALTRUA 2, ESSENTIO, PROPONENT and ACCOLADE models for the family, yet the stated scope concerns only Accolade SL and Accolade EL battery items. A process-change notice records the intended change; it does not itself establish safety or clinical effectiveness.
FDA approval order statement
to implement an additional acceptance activity for Accolade SL batteries and to change a specification for an existing Accolade EL battery specification
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Oct 3, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- N970003/S311
- Regulatory pathway
- PMA supplement
- Applicant
- Boston Scientific Corp
- Product code
- LWP
- Decision code
- OK30
- Decision date
- Oct 3, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Implantable pulse generator, pacemaker (non-CRT).
- Applicant
- Boston Scientific Corp
- Product code
- LWP
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
N970003/S311 received
Application receipt date recorded by FDA.
N970003/S311 · FDA decision
30-Day Notice
Related devices and submissions
Explore the linked device profile
Other records with product code LWP
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Medtronic, Inc. | PMA supplement | Oct 29, 2026 | FDA | |
| Medtronic, Inc. | PMA supplement | Oct 23, 2026 | FDA | |
| Medtronic, Inc. | PMA supplement | Oct 5, 2026 | FDA | |
| Boston Scientific | PMA supplement | Oct 3, 2026 | FDA | |
| Boston Scientific | PMA approval | Apr 25, 2016 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Boston Scientific Corp
- Headquarters
- Not reported
- Brand website
- bostonscientific.com
- FDA applicant address
- 4100 Hamline Ave. N, St Paul, MN, 55112
Sources and methodology
- Original FDA record: N970003/S311
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

